Mark Genovese

Mark Genovese

Corporate Officer/Principal presso ELI LILLY AND COMPANY
Health Technology
Consumer Services

Profilo

Mark Genovese is currently the Senior Vice President-Immunology Development at Eli Lilly & Co. He previously worked as the Director at Kyverna Therapeutics, Inc. and as the Clinical Chief-Immunology & Rheumatology at Stanford University.
From 2020 to 2023, he served as the Senior Vice President-Inflammation Development at Gilead Sciences, Inc. Dr. Genovese completed his undergraduate degree at the University of Notre Dame and obtained his doctorate from The Johns Hopkins University School of Medicine.

Posizioni attive di Mark Genovese

SocietàPosizioneInizio
ELI LILLY AND COMPANY Corporate Officer/Principal 16/10/2023

Precedenti posizioni note di Mark Genovese

SocietàPosizioneFine
GILEAD SCIENCES, INC. Corporate Officer/Principal 01/09/2023
KYVERNA THERAPEUTICS, INC. Direttore/Membro del Consiglio -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Mark Genovese

Formazione di Mark Genovese

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

21

Relazioni di 1° grado

6

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private6

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

  1. Mercati
  2. Insiders
  3. Mark Genovese